HOME >> MEDICINE >> NEWS
Novartis MS drug shows promising results

ronic, disabling disease of the central nervous system affecting twice as many women than men.3 MS has a significant impact on the patient's social activities, employment and overall quality of life. Currently marketed MS therapies afford an average reduction in relapse rates of 30% in two-year studies and require frequent injections ranging from daily to weekly. , , ,

FTY720 Phase II study results
The results are from a large Phase II study conducted at 32 centers in 11 countries (Europe and Canada). In the initial, placebo-controlled part of this study, 281 patients were randomized in equal numbers to receive either placebo, 1.25 mg or 5.0 mg FTY720 orally once-daily for six months. The study evaluated the effect of FTY720 on disease activity as measured by MRI and clinical relapses as well as its tolerability and safety. After six months, patients in the placebo group were re-randomized to receive either FTY720 1.25 mg or 5 mg blinded for an additional six months, while patients already on FTY720 continued their originally-assigned treatment. A total of 98% of the 255 patients who completed the first six months volunteered to continue in the extension phase evaluating the longer-term effects of FTY720.

In the 12-month analysis, both patient groups on FTY720 (1.25 mg and 5 mg) who had experienced a reduction in their annualized relapse rate of more than 50% during the first six months compared to placebo maintained this low relapse rate during the subsequent six-month extension. In those patients who switched from placebo to either 1.25 mg or 5 mg of FTY720 after six months, the annualized relapse rate was reduced by at least 70% during the second six-month study phase compared to the first six months on placebo.

The MRI results at 12 months showed low levels of inflammatory disease activity in all FTY720 groups. In patients who switched from placebo to FTY720, the mean number of inflammatory (Gd-enhancing) lesions on M
'"/>

Contact: Eva Reynolds
eva@reynoldsmackenzie.com
44-207-031-4361
Reynolds-MacKenzie
1-Oct-2005


Page: 1 2 3

Related medicine news :

1. BIDMC investigator receives Novartis Award in Diabetes
2. American Urological Association honors Novartis Pharmaceuticals with annual health science award
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. Most seniors now have drug coverage, U-M study shows
5. Wireless technology shows promise in diagnosing pediatric intestinal disease
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Method shows promise for early detection of pancreatic cancer
8. Organic farming can feed the world, U-M study shows
9. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
10. Borderline personality disorder shows improvements with intensive psychotherapy
11. New drug shows promise in treatment of advanced thyroid cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... , ... The Rise of Mental Health and Substance Abuse During COVID-19, Entering ... needless to say, more complications. With rising deaths, more confirmed cases every day, and ... hard to escape and find peace. Adding to these persistent stressors are quarantine orders. ...
(Date:5/21/2020)... ... 21, 2020 , ... A new report from Kalorama Information, a ... involved in the point of care test industry. Given the need to diagnose ... made point-of-care more important than in the past, according to the market researcher. ...
(Date:5/17/2020)... ... May 18, 2020 , ... R3 Stem ... its Tijuana regenerative clinic. There are two program options for patients and their ... , While it is unclear exactly what causes Autism Spectrum Disorder (ASD), there ...
(Date:5/16/2020)... ... ... On May 21, T1V will host a webinar featuring Dr. David B. Agus, one of ... CBS news, as we address COVID-19 and the impact on unified communication and collaboration. While ... March, many questions are left unanswered as we look at the future of UCC in ...
(Date:5/16/2020)... ... ... Dr. Tomasz Biernacki states that “If bunion and flat foot formation ... keep the foot from being unable to fit into good supportive shoes in the ... flat feet and bunion formation can have further knee pain, hip pain ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Sindledecker Dentistry ... offices had been closed due to the coronavirus pandemic and the practice was ... The office has remained open only for emergency needs and the staff, led ...
(Date:5/21/2020)... ... 21, 2020 , ... MedVet, a leader in emergency and specialty veterinary healthcare, ... Showers Dr., Mountain View, CA in June 2020. MedVet Mountain View joins existing MedVet ... the Silicon Valley and broader Santa Clara County areas. Concurrent to opening MedVet Mountain ...
(Date:5/21/2020)... , ... May 21, 2020 , ... Murrieta Genomics ... (Redefining Early Stage Investments) Conference to offer startup companies a special discount rate ... , The RESI conference series was created by LSN to bring together startups with ...
Breaking Medicine Technology:
Cached News: